REFERENCES
1. Boscolo-Rizzo P, Hummel T, Hopkins C, et al. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation.Rhinology . 2021;59(6):517-527. doi:10.4193/Rhin21.249
2. Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection.Neuroscientist . 2020:85-94. doi:10.1177/1073858420956905
3. Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: Meta-analysis with parametric cure modelling of recovery curves. BMJ . 2022. doi:10.1136/bmj-2021-069503
4. Doty RL. Olfactory dysfunction in COVID-19 : pathology and long-term implications for brain health. 2020;(January).
5. Zazhytska M, Kodra A, Hoagland DA, et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell . 2022;185(6):1052-1064.e12. doi:10.1016/j.cell.2022.01.024
6. Melo GD De, Lazarini F, Levallois S, et al. COVID-19 – related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. 2021;1(June).
7. Saussez S, Sharma S, Thiriard A, et al. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur J Neurol . 2021;28(11):3702-3711. doi:10.1111/ene.14994
8. Levi R, Ubaldi L, Pozzi C, et al. The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients.Commun Med . 2021;1(1). doi:10.1038/s43856-021-00032-0
9. Masiá M, Telenti G, Fernández M, et al. SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized with COVID-19: Viral Load Predicts Antibody Response. Open Forum Infect Dis . 2021;8(2):1-8. doi:10.1093/ofid/ofab005
10. Fröberg J, Gillard J, Philipsen R, et al. SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms. Nat Commun . 2021;12(1):1-11. doi:10.1038/s41467-021-25949-x
11. Sagar M, Reifler K, Rossi M, et al. Recent endemic coronavirus infection is associated with less-severe COVID-19. J Clin Invest . 2021;131(1). doi:10.1172/JCI143380
12. Lechien JR, Chiesa-Estomba CM, Beckers E, et al. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med . 2021;290:451–461. doi:10.1111/joim.13209
13. Oleszkiewicz A, Schriever VA, Croy · I, Hähner · A, Hummel · Thomas. Updated Sniffin’ Sticks normative data based on an extended sample of 9139 subjects. Eur Arch Oto-Rhino-Laryngology . 276:3. doi:10.1007/s00405-018-5248-1
14. Bordi L, Piralla A, Lalle E, et al. Rapid and sensitive detection of SARS-CoV-2 RNA using the SimplexaTM COVID-19 direct assay. J Clin Virol . 2020;128:104416. doi:10.1016/j.jcv.2020.104416
15. Eric P Brown, Anna F Licht, Anne-Sophie Dugast, Ickwon Choi, Chris Bailey-Kellogg, Galit Alter MEA. High-throughput,multiplexed IgG subclassing of antigen-specific antibodies from clinical samples.J Immunol Methods . 2013;386((1-2)):117-123. doi:10.1016/j.jim.2012.09.007.
16. Riccardo Levi1, 2*, Leonardo Ubaldi1, 2*, Chiara Pozzi2, Giovanni Angelotti2, Maria Teresa Sandri1 2, Elena Azzolini1, 2, Michela Salvatici2, Victor Savevski2, Alberto Mantovani1, 2 3, Maria A, Rescigno1 2. The antibody response to SARS-CoV-2 increases over 5 months in patients with anosmia/dysgeusia. 2021;(Mi):1-15. doi:10.1101/2021.02.05.21251219
17. Butler SE, Crowley AR, Natarajan H, et al. Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals. Front Immunol . 2021;11(January):1-14. doi:10.3389/fimmu.2020.618685
18. Brandtzaeg P. Secretory immunity with special reference to the oral cavity. 2013. doi:10.3402/jom.v5i0.20401
19. Jennewein MF, Alter G. The Immunoregulatory Roles of Antibody Glycosylation. Trends Immunol . 2017;38(5):358-372. doi:10.1016/j.it.2017.02.004
20. Afkhami S, D’Agostino MR, Zhang A, et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell . 2022;185(5):896-915.e19. doi:10.1016/j.cell.2022.02.005